Cargando…
Application of vincristine-loaded platelet therapy in three dogs with refractory immune-mediated thrombocytopenia
Three dogs presented with refractory immune-mediated thrombocytopenia (IMT). All patients failed to respond to prednisone, which is considered a mainstay of immunosuppressive therapy. Vincristine-loaded platelets (VLPs), which act selectively on mononuclear phagocytes,were introduced. After the VLPs...
Autores principales: | Park, Hyung-Jin, Kim, Ja-Won, Song, Kun-Ho, Seo, Kyoung-Won |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Korean Society of Veterinary Science
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4367143/ https://www.ncbi.nlm.nih.gov/pubmed/25269722 http://dx.doi.org/10.4142/jvs.2015.16.1.127 |
Ejemplares similares
-
Neutropenia in dogs receiving vincristine for treatment of presumptive immune‐mediated thrombocytopenia
por: LaQuaglia, Kathryn A., et al.
Publicado: (2021) -
Successful management and recovery of a dog with immune‐mediated thrombocytopenia following vincristine overdose
por: Poirier, Maude, et al.
Publicado: (2022) -
Vincristine therapy for severe and refractory immune thrombocytopenia following COVID-19 vaccination
por: Saito, Kei, et al.
Publicado: (2021) -
Influence of Vincristine, Clinically Used in Cancer Therapy and Immune Thrombocytopenia, on the Function of Human Platelets
por: Lien, Li-Ming, et al.
Publicado: (2021) -
Platelet Volume and Plateletcrit in Dogs with Presumed Primary Immune‐Mediated Thrombocytopenia
por: Schwartz, D., et al.
Publicado: (2014)